Black Rock Inc. Volitionrx LTD Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VNRX
# of Institutions
28Shares Held
24.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY12.5MShares$4.12 Million4.96% of portfolio
-
Armistice Capital, LLC New York, NY9.38MShares$3.1 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.53MShares$504,9150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA878KShares$289,7960.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il330KShares$108,7410.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $18.9M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...